Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNS60 in large vessel occlusion stroke with thrombectomy
NCT04693715Phase 2Completed
- Sponsor
- Revalesio Corporation
- Start
- Jul 2021
- Primary completion
- Nov 2023
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of RNS60 in ischemic stroke, sponsored by Revalesio Corporation. Started Jul 2021; status: completed.
02
Drugs
RNS60
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04693715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04693715.